Colorcon will introduce Opadry CA and Opamix at AAPS meeting
Colorcon (Harleysville, PA), a supplier of coatings and excipients for tablets, has introduced two new products, Opadry CA and Opamix, which the company says will replace existing solutions and offer benefits for both manufacturers and patients. The products will be on display at the annual Am. Assn. of Pharmaceutical Scientists meeting (Chicago, Oct. 14-18), also at this week's CPhI meeting in Madrid.
Opadry CA is a fully-formulated, semipermeable coating for osmotic pump tablets, which provide drug release at a constant rate over an extended period of time (as long as 8-12 hours). The first of its kind, the new single-component coating will help lower manufacturing time, saving at least two hours in reduced preparation and coating process time, according to the company. Fewer components involved in the coating process also will translate into lower quality control testing and documentation costs.
Opamix is a pre-formulated additive blend designed for use with BASF Corp.’s Kollicoat Smartseal 30 D, an aqueous dispersion comprising a taste-masking polymer. “Together, they form a complete coating dispersion that is easily prepared and can be readily coated onto tablets or multiparticulates to provide excellent taste-masking performance,” explains Kamlesh Oza, general manager of film coatings for Colorcon.
Like Opadry CA, Opamix is expected to reduce manufacture time (by 40%, according to the company) and lower quality control and documentation costs, due to fewer raw materials needed in production. While masking mildly bad taste may be mitigated by existing coating technologies, Oza says the Opamix/Smartseal combination was developed to be “the preferred option for coatings with superior taste-masking functionality, owing to its demonstrated efficacy, ease of use and stability.” Opamix formulae are available in clear or pigmented versions and can be color-matched by Colorcon.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.